TY  - RPRT
TI  - Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.
AU  - Antonio Ruggiero
AU  - Giorgio Attinà
AU  - Giorgio Placidi
AU  - Elena D'Agostino
AU  - Alessia Amato
AU  - Tommaso Verdolotti
AU  - Stefano Mastrangelo
AU  - Benedetto Falsini
PY  - 2026
DO  - 10.1007/s11060-026-05777-z
UR  - https://pubmed.ncbi.nlm.nih.gov/42681266/
ID  - 42681266
ER  -